Product Images Cevimeline Hydrochloride

This is a drug package of Cevimeline HC1 capsules with each capsule containing 30 mg of the drug. The usual dosage is given in the package insert. The drug must be kept at 20° to 25°C (68° to 77°F), away from children and dispensed in a tight, light-resistant container. The drug is manufactured by Lupin Pharmaceuticals Inc. in Somerset, NJ 08873 and is suitable for prescription only. The given text also provides the NDC number (43386-999-03) and a product code (LA9990300201 Iss. 03/2010) for the capsules.*

Cevimeline HCI is a drug contained in each capsule with a dosage of 30mg. The package insert should be referred to for usual dosage and administration. It's important to keep this drug and all other drugs away from children. Ideally stored at a temperature of 20-25°C, the capsules should be dispensed in a light-resistant, tight container as defined in the USP/NF. This drug is Rx only and manufactured by Lupin Pharmaceuticals Inc. in Baltimore, MD. The batch number is LA9990100201 and the issue date is February 2019.*

This is a description of Cevimeline Hydrochloride capsules which are used for medical purposes only and require a prescription. Each capsule has 30mg of the active ingredient, Cevimeline HCI. The packaging includes dosage instructions and storage recommendations. The product is manufactured by Novel Laboratories and distributed by Lupin Pharmaceuticals. The medication should be kept in a sealed, light-resistant container and away from children. The batch number and issue date are also mentioned.*